Management tracks

Hearing loss company Decibel Therapeutics Inc. (Cambridge, Mass.) named Michael Su as CSO; Paula Cobb as SVP of strategy, portfolio and programs; and John Lee as SVP of pharmaceutical development. Su was SVP of R&D at Agios Pharmaceuticals Inc. (NASDAQ:AGIO). Cobb was SVP of the rare disease group at Biogen Inc. (NASDAQ:BIIB); and Lee was SVP of pharmaceutical development at Infinity Pharmaceuticals Inc. (NASDAQ:INFI).

Oncolytic virus company Oncorus Inc. (Cambridge, Mass.) hired Cyrus Mozayeni as president and CBO. He was VP and global head of business development and alliance management at bluebird bio Inc. (NASDAQ:BLUE). ...